FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900281067> ?p ?o ?g. }

• W2900281067 endingPage "19" @default.
• W2900281067 startingPage "1" @default.
• W2900281067 abstract "The current study was purported to assess the: (i) in vitro toxicity of betulin silver nanoparticles (AgNPs-B), bare and capped with polyethylene glycol (PEG), on two murine melanoma cell lines (B164A5 and B16Ova) and on healthy cell lines (keratinocytes and melanocytes), and (ii) in vivo antitumor efficacy of PEGylated AgNPs-B in an experimental melanoma model. Bare and PEG-capped AgNPs-B were synthesized by a chemical reduction method resulting in stable and non-aggregated spherical AgNPs-B and PEG-AgNPs-B, of narrow size distributions and mean hydrodynamic diameters of 25 nm and 75 nm, respectively. In vitro assessments were achieved by MTT and Annexin V-FITC assays and in vivo evaluation involved non-invasive techniques for the surveillance of the physiological skin parameters changes and histopathological examination of the harvested organs. The in vitro results revealed selective cytotoxicity against melanoma cells, at low doses that are nontoxic to normal cells; higher doses were associated with the loss of selectivity and toxicity for healthy cells. PEGylated formulation of betulin exerted a dose-dependent pro-apoptotic effect, more obvious in the case of B164A5 cells. Histopathological analysis suggested that PEGylated AgNPs-B developed relevant in vivo effects as antimelanoma agents by decreasing the tumor volume and inhibiting the development of secondary tumors." @default.
• W2900281067 created "2018-11-16" @default.
• W2900281067 creator A5002018691 @default.
• W2900281067 creator A5003228747 @default.
• W2900281067 creator A5012359839 @default.
• W2900281067 creator A5015552254 @default.
• W2900281067 creator A5024910295 @default.
• W2900281067 creator A5050827290 @default.
• W2900281067 creator A5069282784 @default.
• W2900281067 creator A5070763192 @default.
• W2900281067 creator A5080971909 @default.
• W2900281067 creator A5084166074 @default.
• W2900281067 creator A5087663618 @default.
• W2900281067 date "2019-01-01" @default.
• W2900281067 modified "2023-10-18" @default.
• W2900281067 title "Betulin silver nanoparticles qualify as efficient antimelanoma agents in in vitro and in vivo studies" @default.
• W2900281067 cites W1573328850 @default.
• W2900281067 cites W1843302206 @default.
• W2900281067 cites W1901637354 @default.
• W2900281067 cites W1965748535 @default.
• W2900281067 cites W1970007893 @default.
• W2900281067 cites W1973836285 @default.
• W2900281067 cites W2014353818 @default.
• W2900281067 cites W2015794080 @default.
• W2900281067 cites W2030578932 @default.
• W2900281067 cites W2035595523 @default.
• W2900281067 cites W2035700665 @default.
• W2900281067 cites W2052512824 @default.
• W2900281067 cites W2052601846 @default.
• W2900281067 cites W2053661334 @default.
• W2900281067 cites W2060972377 @default.
• W2900281067 cites W2068694044 @default.
• W2900281067 cites W2069021161 @default.
• W2900281067 cites W2072985647 @default.
• W2900281067 cites W2082221567 @default.
• W2900281067 cites W2085199490 @default.
• W2900281067 cites W2086264250 @default.
• W2900281067 cites W2097995306 @default.
• W2900281067 cites W2100593340 @default.
• W2900281067 cites W2103089870 @default.
• W2900281067 cites W2104310510 @default.
• W2900281067 cites W2115029038 @default.
• W2900281067 cites W2122827153 @default.
• W2900281067 cites W2139626319 @default.
• W2900281067 cites W2166662937 @default.
• W2900281067 cites W2227263789 @default.
• W2900281067 cites W2275174085 @default.
• W2900281067 cites W2299918777 @default.
• W2900281067 cites W2308908270 @default.
• W2900281067 cites W2317755174 @default.
• W2900281067 cites W2323206491 @default.
• W2900281067 cites W2331195265 @default.
• W2900281067 cites W2331406067 @default.
• W2900281067 cites W2340363319 @default.
• W2900281067 cites W2342174859 @default.
• W2900281067 cites W2343925304 @default.
• W2900281067 cites W2462273684 @default.
• W2900281067 cites W2478478625 @default.
• W2900281067 cites W2501158096 @default.
• W2900281067 cites W2511684231 @default.
• W2900281067 cites W2518825499 @default.
• W2900281067 cites W2521880295 @default.
• W2900281067 cites W2552907949 @default.
• W2900281067 cites W2562352619 @default.
• W2900281067 cites W2565731282 @default.
• W2900281067 cites W2590166853 @default.
• W2900281067 cites W2597521513 @default.
• W2900281067 cites W2604111333 @default.
• W2900281067 cites W2607431306 @default.
• W2900281067 cites W2618795118 @default.
• W2900281067 cites W2735047267 @default.
• W2900281067 cites W2751388768 @default.
• W2900281067 cites W2766146072 @default.
• W2900281067 cites W2775350181 @default.
• W2900281067 cites W2777920826 @default.
• W2900281067 cites W2789566348 @default.
• W2900281067 cites W2794062596 @default.
• W2900281067 cites W2794188423 @default.
• W2900281067 cites W4319425399 @default.
• W2900281067 doi "https://doi.org/10.1016/j.ejpb.2018.11.006" @default.
• W2900281067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30414497" @default.
• W2900281067 hasPublicationYear "2019" @default.
• W2900281067 type Work @default.
• W2900281067 sameAs 2900281067 @default.
• W2900281067 citedByCount "20" @default.
• W2900281067 countsByYear W29002810672020 @default.
• W2900281067 countsByYear W29002810672021 @default.
• W2900281067 countsByYear W29002810672022 @default.
• W2900281067 countsByYear W29002810672023 @default.
• W2900281067 crossrefType "journal-article" @default.
• W2900281067 hasAuthorship W2900281067A5002018691 @default.
• W2900281067 hasAuthorship W2900281067A5003228747 @default.
• W2900281067 hasAuthorship W2900281067A5012359839 @default.
• W2900281067 hasAuthorship W2900281067A5015552254 @default.
• W2900281067 hasAuthorship W2900281067A5024910295 @default.
• W2900281067 hasAuthorship W2900281067A5050827290 @default.
• W2900281067 hasAuthorship W2900281067A5069282784 @default.
• W2900281067 hasAuthorship W2900281067A5070763192 @default.

• next